# Lonza Tampa LLC, Tampa, FL – FDA Inspections

Source: https://www.keypedia.com/companies/lonza-tampa-llc/6ba00e57-ba56-45fd-9718-cb91a9b2458a

> Inspection records and compliance data for Lonza Tampa LLC in Tampa, Florida. 7 FDA inspections on record (1 OAI), 5 Form 483s, last inspected August 22, 2025.

---

## Details

- Name: Lonza Tampa LLC
- FEI Number: 3001549109
- Business Operations: API MANUFACTURE, API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK, REPACK
- Address Line 1: 4910 Savarese Cir
- City: Tampa
- State: Florida
- Zip Code: 33634
- Country Name: United States
- Address: 4910 Savarese Cir, Tampa, Florida 33634, United States
- Country: United States

## Related Documents

- [483 - Lonza Tampa LLC - 2025-08-22](https://www.keypedia.com/records/483/lonza-tampa-llc/68efbeac-f0f1-4a6a-988f-78e17ff65265) — source: FDA, date: August 22, 2025
- [FDA Inspection 1279220 - Lonza Tampa LLC - 2025-08-22](https://www.keypedia.com/records/fda_inspections/lonza-tampa-llc/845ddaff-d6ea-4588-873f-96b7876f2b12) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 22, 2025
- [483 - Lonza Tampa LLC - 2025-08-18](https://www.keypedia.com/records/483/lonza-tampa-llc/2adf80d8-45eb-4678-b02d-357f1ab62fb4) — source: FDA, date: August 18, 2025
- [483 - Lonza Tampa LLC - 2023-09-29](https://www.keypedia.com/records/483/lonza-tampa-llc/a8ece597-358f-4cab-bfef-326e617b4a58) — source: FDA, date: September 29, 2023
- [FDA Inspection 1219089 - Lonza Tampa LLC - 2023-09-29](https://www.keypedia.com/records/fda_inspections/lonza-tampa-llc/19b78cad-b668-40df-9a5f-f84d559f5ae6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 29, 2023
- [483 - Lonza Tampa LLC - 2021-10-01](https://www.keypedia.com/records/483/lonza-tampa-llc/252f0240-687e-4549-aebb-d7383ba3caf8) — source: FDA, date: October 1, 2021
- [FDA Inspection 1153431 - Lonza Tampa LLC - 2021-10-01](https://www.keypedia.com/records/fda_inspections/lonza-tampa-llc/67f90e25-ceaf-40da-b291-93f442ae461f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 1, 2021
- [EIR - Lonza Tampa LLC - 2018-07-20](https://www.keypedia.com/records/eir/lonza-tampa-llc/f0a6f1c2-6e62-429a-9a89-2a808a0e0fe4) — source: FDA, date: July 20, 2018
- [FDA Inspection 1059866 - Lonza Tampa LLC - 2018-07-20](https://www.keypedia.com/records/fda_inspections/lonza-tampa-llc/8008cb01-dd6e-43ad-8f13-fc56c1f35d7b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 20, 2018
- FDA Inspection 1059866 - Lonza Tampa LLC - 2018-07-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 20, 2018
- [FDA Inspection 1017944 - Lonza Tampa LLC - 2017-07-14](https://www.keypedia.com/records/fda_inspections/lonza-tampa-llc/45aa53cf-ea96-4151-a6fb-734cccd3b240) — classification: Official Action Indicated (OAI), source: FDA, date: July 14, 2017
- FDA Inspection 1017944 - Lonza Tampa LLC - 2017-07-14 — classification: Official Action Indicated (OAI), source: FDA, date: July 14, 2017
- FDA Inspection 1017944 - Lonza Tampa LLC - 2017-07-14 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 14, 2017
- [FDA Inspection 997589 - Lonza Tampa LLC - 2017-01-13](https://www.keypedia.com/records/fda_inspections/lonza-tampa-llc/1fd078e0-c2ae-4ea2-a216-d32eeb37fa03) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 13, 2017
- [FDA Inspection 551193 - Lonza Tampa LLC - 2008-12-10](https://www.keypedia.com/records/fda_inspections/lonza-tampa-llc/517827c4-138a-4338-814b-85e0acd9913c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 10, 2008

## Related Companies

- [Airgas USA, LLC](https://www.keypedia.com/companies/airgas-usa-llc/54385888-293d-453c-bb90-38e772b1964f)
- [Abon Pharmaceuticals, LLC](https://www.keypedia.com/companies/abon-pharmaceuticals-llc/544e3808-101a-4362-aea9-76f7f5356f5a)
- [Alick's Home Medical Equipment, Inc.](https://www.keypedia.com/companies/alicks-home-medical-equipment-inc/f196dc27-60ea-4d47-bd5d-91c9be2719f3)
- [Linde Gas & Equipment Inc.](https://www.keypedia.com/companies/linde-gas-equipment-inc/796daf9f-80a4-495a-b2ae-aa46d3d9ae73)
- [Dixon Investments Inc](https://www.keypedia.com/companies/dixon-investments-inc/ce191609-e6f1-4391-8f04-21996703095d)
- [Linde, Inc. dba Praxair, Inc](https://www.keypedia.com/companies/linde-inc-dba-praxair-inc/e373ec1f-fe25-449c-b9eb-8ccf361ea32e)
- [REGI US INC](https://www.keypedia.com/companies/regi-us-inc/0596d9b3-58c6-48ab-89fb-096ab585b2dd)
- [Purdue Pharmaceuticals LP](https://www.keypedia.com/companies/purdue-pharmaceuticals-lp/404112a8-6b5a-4bea-9890-9c5f6339ca44)
- [Avadel CNS Pharmaceuticals LLC](https://www.keypedia.com/companies/avadel-cns-pharmaceuticals-llc/6ed86f03-0d25-4dd6-91c0-b0c3725ceaa8)
- [KDC/ONE SOCAL LABORATORIES, LLC](https://www.keypedia.com/companies/kdcone-socal-laboratories-llc/d02dae40-fdd7-4623-934b-cb99482e07c9)

## Related Officers

- [Scott T. Ballard](https://www.keypedia.com/people/scott-t-ballard/09b2ae9a-3b30-45bd-bac1-437365e938da)
- [company_representative](https://www.keypedia.com/people/jeremy-nash/3097b96b-eabc-4695-b7ab-a238ff2cc319)
- [Pharmaceutical Investigator](https://www.keypedia.com/people/kayla-v-sprague/154cb543-111b-4ad1-b45b-43900df71b90)
- [Lillian M Colon-McKnight](https://www.keypedia.com/people/lillian-m-colon-mcknight/ce6346b7-a006-4f84-afba-9fdda488042d)
- [Suzanne B Valdez](https://www.keypedia.com/people/suzanne-b-valdez/e0dd13bc-023e-47ec-850c-95bdde545002)
- [ CSO](https://www.keypedia.com/people/megan-t-ziegler/3e83a317-701a-4e40-bb43-34d294d3448f)